167 related articles for article (PubMed ID: 24683542)
21. Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype.
Conceição M; Mendonça L; Nóbrega C; Gomes C; Costa P; Hirai H; Moreira JN; Lima MC; Manjunath N; Pereira de Almeida L
Biomaterials; 2016 Mar; 82():124-37. PubMed ID: 26757259
[TBL] [Abstract][Full Text] [Related]
22. miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells.
Yu G; Li H; Wang J; Gumireddy K; Li A; Yao W; Tang K; Xiao W; Hu J; Xiao H; Lang B; Ye Z; Huang Q; Xu H
J Urol; 2014 Oct; 192(4):1229-37. PubMed ID: 24866595
[TBL] [Abstract][Full Text] [Related]
23. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
Cao W; Fan R; Wang L; Cheng S; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):963-71. PubMed ID: 23264087
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
26. Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery.
Tsuji T; Yoshitomi H; Usukura J
Microscopy (Oxf); 2013 Jun; 62(3):341-52. PubMed ID: 23204307
[TBL] [Abstract][Full Text] [Related]
27. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
Mendonça LS; Firmino F; Moreira JN; Pedroso de Lima MC; Simões S
Bioconjug Chem; 2010 Jan; 21(1):157-68. PubMed ID: 20000596
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
Tivnan A; Tracey L; Buckley PG; Alcock LC; Davidoff AM; Stallings RL
BMC Cancer; 2011 Jan; 11():33. PubMed ID: 21266077
[TBL] [Abstract][Full Text] [Related]
29. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
[TBL] [Abstract][Full Text] [Related]
30. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models.
Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
Mol Pharm; 2012 Jul; 9(7):1919-31. PubMed ID: 22616905
[TBL] [Abstract][Full Text] [Related]
31. Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro.
He J; Jiang YL; Wang Y; Tian XJ; Sun SR
Chin Med J (Engl); 2020 Apr; 133(7):800-807. PubMed ID: 32149762
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
33. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1.
Zhang L; He S; Guo S; Xie W; Xin R; Yu H; Yang F; Qiu J; Zhang D; Zhou S; Zhang K
J Diabetes Complications; 2014; 28(3):259-64. PubMed ID: 24560136
[TBL] [Abstract][Full Text] [Related]
36. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
37. The influence of coupling transferrin to liposomes or minibeads on its uptake and fate in leukemic L2C cells.
Vidal M; Sainte-Marie J; Philippot JR; Bienvenue A
FEBS Lett; 1987 May; 216(1):159-63. PubMed ID: 3582664
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 Polyunsaturated Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance Dexamethasone Sensitivity in Multiple Myeloma Cells by the p53/miR-34a/Bcl-2 Axis.
Dai X; Li M; Geng F
Biochemistry (Mosc); 2017 Jul; 82(7):826-833. PubMed ID: 28918747
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H
Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779
[TBL] [Abstract][Full Text] [Related]
40. Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer.
Wu XD; Song YC; Cao PL; Zhang H; Guo Q; Yan R; Diao DM; Cheng Y; Dang CX
Med Oncol; 2014 Apr; 31(4):894. PubMed ID: 24573638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
